We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A lethal psychedelic drug should be controlled as a Class A substance, according to the Advisory Council on the Misuse of Drugs (ACMD).
A review of MDMA (‘ecstasy’), its harms and classification under the Misuse of Drugs Act 1971 (2009). The Advisory Council on the Misuse of…
The chair of the Advisory Council on the Misuse of Drugs writes to Karen Bradley about Pregabalin and Gabapentin.
Government response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237.
The Advisory Council on the Misuse of Drugs has provided an updated harms assessment of alkyl nitrites.
In October 2010 the minister responsible for drugs asked the ACMD to review khat by considering the available evidence and to advise the government…
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
The Advisory Council on the Misuse of Drugs has undertaken a review of the availability and implementation of naloxone in the UK.
This report by the Advisory Council on the Misuse of Drugs investigates the increase of drug-related deaths in the UK.
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances.
Report by the Advisory Council on the Misuse of Drugs (ACMD) reviewing the use of cocaine powder and its impact on British society.
ACMD’s report on diversion and illicit supply of medicines.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
The government’s response to the ACMD’s fentanyl report.
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
ACMD advice on tramadol, February 2013
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).